XML 23 R12.htm IDEA: XBRL DOCUMENT
v3.25.2

Commitments and Contingencies | 6 Months Ended
--- | ---
Jun. 30, 2025
Commitments and Contingencies [Abstract] |
Commitments and Contingencies | NOTE 6 – Commitments and Contingencies Office Lease Effective November 2023, the Company leased office space for a two-year term. The Company’s office lease contained a renewal option. The Company evaluated several factors in assessing whether there is reasonable certainty that the Company will exercise its contractual renewal option concluding that it is not reasonably certain to exercise such option. As it is not reasonably certain to be exercised, the Company excluded the renewal term in determining the lease term used in calculating the ROU asset and lease liability. In December 2024, the landlord notified the Company that it will be closing its operations at the Company’s location and offered to relocate the Company to a new location. The Company agreed to relocate and accordingly, on December 9, 2024, the Company and the landlord entered into a new lease agreement (the “December 2024 Lease”). Pursuant to the December 2024 Lease, effective December 20, 2024, the Company leased office space for a term of 14 months, expiring on February 28, 2026. Pursuant to the December 2024 Lease, the Company is required to pay a monthly base rent of $2,732 from March 1, 2025 through February 2026. In connection with December 2024 Lease, in December 2024, the Company increased ROU assets and lease liabilities by $31,075 and removed all remaining ROU assets and lease liabilities associated with the November 2023 lease. The table below presents certain information related to the Company’s lease costs, which are included in general and administrative expenses in the accompanying unaudited condensed consolidated statements of operation and comprehensive loss.
|  | Three Months Ended June 30, |  |  | Six Months Ended June 30, |
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Operating lease expense |  | $ | 7,124 |  |  | $ | 5,615 |  |  | $ | 14,539 |  |  | $ | 14,232 |
Short-term lease expense |  |  | 5,715 |  |  |  | 5,840 |  |  |  | 11,375 |  |  |  | 10,493 |
Total lease cost |  | $ | 12,839 |  |  | $ | 11,455 |  |  | $ | 25,914 |  |  | $ | 24,725 |
ROU asset for operating leases was recorded in the condensed consolidated balance sheets as follows:
|  | June 30, 2025 |  |  | December 31, 2024 |
Office lease ROU asset |  | $ | 31,075 |  |  | $ | 31,075 |
Less: accumulated amortization |  |  | (12,994 | ) |  |  | - |
Total ROU asset, net |  | $ | 18,081 |  |  | $ | 31,075 |
Operating lease liability for operating leases was recorded in the condensed consolidated balance sheets as follows:
|  | June 30, 2025 |  |  | December 31, 2024 |
Current portion of operating lease liability |  | $ | 21,326 |  |  | $ | 28,366 |
Long-term portion of operating lease liability |  |  | - |  |  |  | 2,709 |
Total operating lease liability |  | $ | 21,326 |  |  | $ | 31,075 |
Supplemental cash flow information related to the Company’s leases for the six months ended June 30, 2025 was as follows:
Cash paid for amounts included in the measurement of lease liabilities: |  |  |
Operating cash flows for operating leases |  | $ | 2,732 |
The weighted-average remaining lease term for the operating lease is 0.67 years and the weighted-average incremental borrowing rate is 10% as of June 30, 2025 and December 31, 2024. As of June 30, 2025, future annual minimum lease payments required under operating leases are as follows:
2025 (remainder of year) |  | $ | 16,392 |
2026 |  |  | 5,750 |
Total minimum lease payments |  |  | 22,142 |
Less: effects of discounting |  |  | (816 | )
Present value of future minimum lease payments |  | $ | 21,326 |
Other On December 23, 2024, the Company provided notice to Isoprene Pharmaceutical, Inc. (“Isoprene”) of its intent to terminate the exclusive license agreement (the “Isoprene Agreement”) by and between the Company and Isoprene dated July 2, 2021. The Isoprene Agreement terminated on March 23, 2025.

X
- References No definition available. + Details
Name: | us-gaap_CommitmentsAndContingenciesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for commitments and contingencies. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 405 -SubTopic 30 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/405-30/tableOfContent Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 440 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 450 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/450/tableOfContent Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 954 -SubTopic 440 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 440 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4 Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 440 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/440/tableOfContent + Details
Name: | us-gaap_CommitmentsAndContingenciesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration